b-LACTAM-GRAFTED SPIROOXINDOLOPYRROLIDINE
2753
4.39–4.41 (dd, 1H, J ¼ 4.8, 2.4 Hz), 4.55 (d, 1H, J ¼ 8.4 Hz), 5.17 (d, 1H, J ¼ 2.1 Hz),
6.58–7.40 (m, Ar-H, 17H), 8.24 (s, 1H, N-H); 13 C NMR (CDCl3, 75 MHz): d 41.97,
53.48, 54.36, 55.40, 55.68, 61.09, 68.35, 68.45, 109.17, 114.07, 118.95, 122.53, 126.36,
127.35, 127.68, 128.05, 128.47, 128.96, 129.02, 130.69, 134.31, 135.78, 140.38, 143.94,
156.26, 166.25, 181.32 and 195.74. Mass spectrum (EI, 70 eV): m=z 591.19 (Mþ).
Anal. calcd. for C35H30ClN3O4: C, 71.00; H, 5.11; N, 7.10%. Found: C, 71.16;
H, 5.20; N, 7.02%.
1-N-Methyl-2-[1’-N-(p-methoxyphenyl)-3’-phenylazetidine-2’-one]-3-(p-
bromobenzoyl) spiro[4.300]oxindolo pyrrolidine, 4c. White solid, 85% (0.54 g);
mp 265–267 ꢂC; IR (KBr): 1738, 1708 and 1625 cmꢀ1
;
1H NMR (CDCl3,
300 MHz): d 2.21 (s, 3H, NCH3), 2.95 (d, 1H, NCH2, J ¼ 10.3 Hz), 3.57 (d, 1H,
NCH2, J ¼ 10.3 Hz), 3.79 (s, 3H, OCH3), 4.23–4.27 (dd, 1H, J ¼ 8.1, 4.8 Hz),
4.41–4.43 (dd, 1H, J ¼ 4.8, 2.4 Hz), 4.56 (d, 1H, J ¼ 8.4 Hz), 5.15 (d, 1H, J ¼ 2.1 Hz),
6.57–7.37 (m, Ar-H, 17H), 7.85 (s, 1H, N-H); 13 C NMR (CDCl3, 75 MHz): d 42.26,
53.52, 54.36, 55.49, 55.83, 60.03, 68.26, 68.55, 109.57, 114.04, 119.06, 122.61, 126.21,
127.22, 127.34, 128.04, 128.30, 128.90, 129.74, 130.77, 132.58, 137.09, 140.47, 143.89,
156.17, 166.27, 181.39 and 195.60. Mass spectrum (EI, 70 eV): m=z 635.14 (Mþ).
Anal. calcd. for C35H30BrN3O4: C, 66.04; H, 4.75; N, 6.60%; Found: C, 66.12;
H, 4.68; N, 6.69%.
1-N-Methyl-2-[1’-N-(p-methoxyphenyl)-3’-phenylazetidine-2’-one]-3-(p-
methylbenzoyl) spiro[4.300]oxindolo pyrrolidine, 4d. Colorless crystals, 75%
1
(0.42 g); mp 263–265 ꢂC; IR (KBr): 1739, 1706 and 1630 cmꢀ1; H NMR (CDCl3,
300 MHz): d 2.24 (s, 3H, NCH3), 2.43 (s, 3H, CH3), 2.92 (d, 1H, NCH2, J ¼ 10.3 Hz),
3.53 (d, 1H, NCH2, J ¼ 10.3 Hz), 3.75 (s, 3H, OCH3), 4.22–4.26 (dd, 1H, J ¼ 8.1,
13
4.8 Hz), 4.40–4.42 (dd, 1H, J ¼ 2.4, 4.8 Hz), 4.53 (d, 1H, J ¼ 8.4 Hz), 5.15 (d, 1H,
J ¼ 2.1 Hz), 6.56–7.41 (m, Ar-H, 17H), 8.14 (s, 1H, N-H);
C NMR (CDCl3,
75 MHz): d 21.53, 40.99, 53.42, 54.38, 55.42, 55.73, 60.94, 68.24, 68.50, 109.37,
113.93, 118.93, 122.52, 126.31, 127.37, 127.76, 128.00, 128.37, 128.82, 128.98,
130.77, 134.21, 135.73, 140.31, 143.86, 156.16, 166.17, 181.29 and 195.62. Mass spec-
trum (EI, 70 eV): m=z 571.25 (Mþ). Anal. calcd. for C36H33N3O4: C, 75.64; H, 5.82;
N, 7.35%. Found: C, 75.73; H, 5.96; N, 7.27%.
1-N-Methyl-2-[1’-N-(p-methoxyphenyl)-3’-phenylazetidine-2’-one]-3-(p-
methoxybenzoyl) spiro[4.300]oxindolo pyrrolidine, 4e. Colorless crystals, 84%
1
(0.42 g); mp 255–258 ꢂC; IR (KBr): 1738, 1708 and 1626 cmꢀ1; H NMR (CDCl3,
300 MHz): d 2.44 (s, 3H, NCH3), 2.95 (d, 1H, NCH2, J ¼ 10.3 Hz), 3.56 (d, 1H,
J ¼ 10.3 Hz), 3.72 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 4.26–3.30 (dd, 1H, J ¼ 8.1,
4.8 Hz), 4.42–4.44 (dd, 1H, J ¼ 4.8, 2.4 Hz), 4.53 (d, 1H, J ¼ 8.4 Hz), 6.49–7.41 (m,
Ar-H, 17H), 9.15 (s, 1H, N-H); 13C NMR (CDCl3, 75 MHz): d 40.98, 52.87,
54.57, 55.27, 55.42, 56.57, 60.84, 68.31, 68.71, 109.67, 113.92, 118.88, 122.52,
126.34, 127.42, 127.82, 128.09, 128.34, 128.48, 128.85, 129.98, 130.67, 133.56,
135.72, 140.57, 156.31, 166.18, 181.97 and 194.28. Mass spectrum (EI, 70 eV): m=z
587.24 (Mþ). Anal. calcd. for C36H33N3O5: C, 73.58; H, 5.66; N, 7.15%. Found:
C, 73.65; H, 5.78; N, 7.06%.